NDMA senna task group requests meeting with FDA on OTC laxative ingredient's safety..
This article was originally published in The Tan Sheet
Executive Summary
NDMA SENNA TASK GROUP REQUESTS MEETING WITH FDA to discuss the safety of the OTC laxative ingredient. In a Nov. 5 letter to the agency, NDMA Senior VP and Director of Science & Technology William Soller, PhD, suggested that members of the task group and Center for Drug Evaluation & Research officials meet to address FDA's "concerns with the safety of senna."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning